|
Pharma Eurasia 2026 to position Tashkent as the gateway to the CIS pharmaceutical market
|
|
Tashkent, Uzbekistan
March 18 , 2026
|
|
|
 The global pharmaceutical industry will converge in Tashkent, Uzbekistan, from 20–22 May 2026 for Pharma Eurasia 2026, an international exhibition and summit aimed at strengthening pharmaceutical trade, manufacturing partnerships, and regulatory collaboration across Central Asia, the CIS, and the broader Eurasian region. The event will take place at Tashkent Pharma Park, a flagship pharmaceutical manufacturing hub developed as part of Uzbekistan’s ambitious healthcare and life sciences expansion strategy.
Pharma Eurasia aligns with the national vision of H. E. Shavkat Mirziyoyev, President of Republic of Uzbekistan whose government has prioritized the development of a self-sufficient pharmaceutical ecosystem and the transformation of Uzbekistan into a strategic gateway for pharmaceutical trade
across the CIS region.
Strengthening the Eurasian Pharmaceutical Ecosystem
Pharma Eurasia 2026 will bring together pharmaceutical manufacturers,technology providers, contract manufacturers, equipment suppliers,regulators, investors, and supply chain leaders from across the global pharmaceutical industry.
The exhibition will showcase innovations and solutions across key industry segments including:
• Pharma, Nutraceutical & Herbal Formulations
• Active Pharmaceutical Ingredients (APIs)
• Finished Drug Formulations (FDF)
• Third Party Contract Manufacturers
• Pharmaceutical Machinery & Processing Equipment
• Packaging & Drug Delivery Systems
• Laboratory & R&D Technologies
• Cold Chain & Pharmaceutical Logistics
The event is expected to host:
• 300+ Exhibitors
• 3,000+ International Trade Visitors
• 300+ Hosted Buyers from CIS and Eurasian markets
Participating companies will have the opportunity to connect with senior decision-makers from Uzbekistan, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Azerbaijan, Georgia, Armenia, Russia, Belarus, and other CIS markets.
Strategic Industry Platforms
Pharma Eurasia 2026 will feature several high-level programs designed to facilitate market access and business collaboration.
Hosted Buyer Programme
A curated B2B matchmaking platform connecting exhibitors with procurement heads, plant directors, distributors, and pharmaceutical investors from across the CIS and Eurasian region. Pre-scheduled meetings will enable exhibitors to establish strategic partnerships and expand regional distribution networks.
Regulators’ Conclave
An exclusive forum bringing together drug regulatory authorities, policymakers, and industry leaders to discuss regulatory pathways, market entry strategies, and investment opportunities across Central Asia and the CIS markets.
Market Entry Assistance Programme
Participating companies will benefit from direct support from Pharm Service State Institution, the nodal agency supporting pharmaceutical development under the Ministry of Health of the Republic of Uzbekistan.
The programme will provide guidance on:
• GMP, GDP, GPP and other GxP standards
• Inspection procedures and dossier requirements
• Registration and certification processes
• Distribution of regulatory information in Uzbek, Russian and English
Growing Global Participation
Pharma Eurasia 2026 is witnessing strong international interest, with pharmaceutical manufacturers and technology providers expected to participate from across India, South Korea, Turkey, Armenia, the United States, the United Kingdom, China, and several European countries.
The event will feature country delegations and international pavilions, bringing together companies seeking manufacturing partnerships, technology collaborations, and market expansion opportunities across Uzbekistan, Central Asia, and the wider CIS region.
Uzbekistan: An Emerging Pharmaceutical Hub
With the development of Tashkent Pharma Park and strong policy support from the government, Uzbekistan is rapidly emerging as a regional pharmaceutical manufacturing and export hub. Its strategic geographic location enables pharmaceutical companies to access over 250 million consumers across Central Asia and the CIS, making the country an attractive destination for international pharmaceutical investment and partnerships.
A Gateway for Global Pharma
Pharma Eurasia 2026 aims to establish Tashkent as a central meeting point for global pharmaceutical stakeholders seeking entry into the CIS and Eurasian markets. With the combined support of government institutions, industry associations, and international pharmaceutical companies, the event is expected to play a key role in accelerating pharmaceutical trade, technology transfer, and healthcare innovation across the region.
Official Statements
Abdulla Azizov, First Deputy Minister of Health of the Republic of Uzbekistan and Chairman of the Pharmaceutical Industry Development Agency, stated, “Uzbekistan is steadily positioning itself as a strategic gateway between global pharmaceutical manufacturers and the rapidly expanding markets of Central Asia and the CIS. Platforms such as Pharma Eurasia play an important role in strengthening international cooperation, facilitating technology transfer, and attracting investment into our pharmaceutical sector. Through initiatives like Tashkent Pharma Park and our continued engagement with global industry leaders, we aim to build a transparent, innovation-driven ecosystem that supports sustainable pharmaceutical manufacturing and trade across the region.”
Kamila Mirzaeva, Chief International Relations Specialist, Ministry of Health, Republic of Uzbekistan, said, “Uzbekistan today presents a unique opportunity for international pharmaceutical companies seeking access to Central Asian and CIS markets. Through collaborative platforms such as Pharma Eurasia, we are strengthening institutional partnerships, regulatory dialogue, and investment facilitation between Uzbekistan and the global pharmaceutical industry. Our focus is to encourage joint ventures, technology transfer, and localization of production so that international cooperation translates into tangible projects that support healthcare development across the region.”
M. Harikrishnan, Project Director – Pharma Eurasia, stated, “Pharma Eurasia has been conceived as more than an exhibition — it is a strategic platform connecting global pharmaceutical innovation with the rapidly emerging markets of Central Asia and the CIS. By bringing together manufacturers, technology providers, regulators, investors, and supply chain leaders, the event creates a structured ecosystem where dialogue transforms into partnerships. Our objective is to position Tashkent as a meeting point for the global pharmaceutical industry and a gateway for companies looking to expand into the Eurasian region.”
Event Details
Pharma Eurasia 2026
20–22 May 2026
Tashkent Pharma Park, Tashkent, Uzbekistan
More info: Contact M. Harikrishnan | +91-952-697-4225 | +998-901-864-333
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|